Obesity Drugs Stay Private as State Considers Public Access

This report highlights that obesity medications endorsed by the WHO are currently unavailable to patients in the public healthcare sector. The state is deliberating on whether to introduce these drugs for public use, but no decision has been finalized yet.

Originally published by gnews